Volume 19, Issue 1 , Pages 72-79, January 2008
Comparative Evaluation of Noninvasive Compression Adjuncts for Hemostasis in Percutaneous Arterial, Venous, and Arteriovenous Dialysis Access Procedures
Purpose
To assess the relative efficacy of three compression adjuncts—D-Stat Dry (D-Stat), QR Powder (QR), and XS Powder (XS)—for reducing time to hemostasis in patients who underwent diagnostic and interventional percutaneous procedures.
Materials and Methods
D-Stat, QR, or XS was applied in 176 percutaneous diagnostic arterial, therapeutic arterial, venous, and arteriovenous dialysis access (AVDA) procedures in 138 patients. The mean time to hemostasis and application-related complications were retrospectively assessed.
Results
Mean time to hemostasis was significantly reduced in all applications of QR (3.1 minutes ± 1.1) and XS (3.7 minutes ± 1.1) relative to D-Stat (6.2 minutes ± 1.1, P < .001 vs both). For therapeutic arterial procedures, mean time to hemostasis for QR and XS was 3.6 minutes ± 1.1 and 4.8 minutes ± 1.1, respectively, and this was significantly less than that of D-Stat (10.0 minutes ± 1.2; P < .001 vs QR, P < .01 vs XS). Mean times to hemostasis for QR and XS were also shorter than that with D-Stat in diagnostic arterial and AVDA procedures (P < .05). For venous procedures, mean time to hemostasis for QR (1.9 minutes ± 1.2) was significantly shorter than that with both D-Stat (4.0 minutes ± 1.2, P < .05) and XS (3.7 minutes ± 1.2, P < .05). Minor immediate complications (hematoma <5 cm) occurred in 2.8% of applications. No access site infections were observed.
Conclusions
All three agents effectively reduced time to hemostasis with minimal associated complications. QR was found to be more effective than D-Stat in all four procedure types.
To access this article, please choose from the options below
PII: S1051-0443(07)01138-4
doi:10.1016/j.jvir.2007.08.028
© 2008 SIR. Published by Elsevier Inc. All rights reserved.
Volume 19, Issue 1 , Pages 72-79, January 2008
